Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $8.00 target price on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 436.91% from the company’s previous close. […]
Related Keywords
Aziyo Biologics , Aziyo Biologics Inc , Aziyo Biologics Company Profile , Cantor Fitzgerald , Renaissance Technologies , Geode Capital Management , Verdence Capital Advisors , Nasdaq , Get Free Report , Street Group , Capital Advisors , Capital Management , Prosight Management , Aziyo Biologics Daily , Nasdaq Azyo , Azyo , Medical , Reiterated Rating ,
comparemela.com © 2020. All Rights Reserved.